Alternatives to allogeneic blood transfusions

Best Practice and Research in Clinical Anaesthesiology

Volumn 21, Issue 2, 2007, Pages 221-239

  Pape, Andreas ^a   Habler, Oliver ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b KRANKENHAUS NORDWEST   (Germany)

Author keywords

alternatives; anaemia tolerance; artificial O2 carriers; blood; blood substitutes; cell salvage; donation; haemodilution; transfusion

Indexed keywords

ANTIBIOTIC AGENT; DIASPIRIN CROSSLINKED HEMOGLOBIN; DIAZEPAM; ENFLURANE; ERYTHROPOIETIN; FLUOROCARBON; HEMOGLOBIN; HEMOSPAN; IRON; ISOFLURANE; MIDAZOLAM; MORPHINE; OXYGEN; PANCURONIUM; PENTOBARBITAL; PERFLUOROOCTYL BROMIDE; PHP; PLASMA SUBSTITUTE; POLYMERIZED HEMOGLOBIN; PROPOFOL; R HB 11; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HEMOGLOBIN; RHB 20; ROCURONIUM; SUFENTANIL; UNCLASSIFIED DRUG; VECURONIUM;

ALLOIMMUNIZATION; ANEMIA; ARTERY RESISTANCE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION REACTION; CHILL; CLINICAL TRIAL; COLLOID; COST EFFECTIVENESS ANALYSIS; CRYSTALLOID; DRUG COST; DRUG FEVER; DRUG INDUCED HEADACHE; ELECTIVE SURGERY; ENZYME ACTIVITY; FLU LIKE SYNDROME; FLUID RESUSCITATION; HEART OUTPUT; HEMATOCRIT; HEMODILUTION; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HUMAN; ILEUS; IMMUNE DEFICIENCY; INFECTION RISK; JAUNDICE; LOW DRUG DOSE; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN DISSOCIATION CURVE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; TISSUE OXYGENATION; TRANSFUSION RELATED ACUTE LUNG INJURY;

ANEMIA; BLOOD DONORS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; CONSUMER PRODUCT SAFETY; ERYTHROPOIETIN, RECOMBINANT; HEMATOCRIT; HEMODILUTION; HEMOGLOBINS; HUMANS; INTRAOPERATIVE PERIOD; OXYGEN; PREOPERATIVE CARE;

EID: 34249995380     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2007.02.004     Document Type: Review

References (101)

1. Goodnough L.T. Risks of blood transfusion. Critical Care Medicine 31 (2003) S678-S686
2. Madjdpour C., Heindl V., and Spahn D.R. Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiologica 72 (2006) 283-298
3. Hebert P.C., Wells G.A., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England Journal of Medicine 340 (1999) 409-417
4. Vincent J.L., Baron J.F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA: The Journal of the American Medical Association 288 (2002) 1499-1507
5. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Critical Care Medicine 32 (2004) 39-52
6. Taylor R.W., O'Brien J., Trottier S.J., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Critical Care Medicine 34 (2006) 2302-2308
7. Palmieri T.L., Caruso D.M., Foster K.N., et al. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Critical Care Medicine 34 (2006) 1602-1607
8. Varney S.J., and Guest J.F. The annual cost of blood transfusions in the UK. Transfusion Medicine (Oxford, England) 13 (2003) 205-218
9. Goodnough L.T., Shander A., and Brecher M.E. Transfusion medicine: looking to the future. Lancet 361 (2003) 161-169
10. Messmer K.F. Acceptable hematocrit levels in surgical patients. World Journal of Surgery 11 (1987) 41-46
11. Spahn D.R., and Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 93 (2000) 242-255
12. Habler O.P., and Messmer K.F. The physiology of oxygen transport. Transfusion Science 18 (1997) 425-435
13. Cain S.M. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. Journal of Applied Physiology 42 (1977) 228-234
14. Meier J.M., Kemming G.I., Kisch-Wedel H., et al. Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology 100 (2004) 70-76
15. Fontana J.L., Welborn L., Mongan P.D., et al. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesthesia and Analgesia 80 (1995) 219-225
16. Zollinger A., Hager P., Singer T., et al. Extreme hemodilution due to massive blood loss in tumor surgery. Anesthesiology 87 (1997) 985-987
17. van Citters R.L., and Franklin D.L. Cardiovascular performance of Alaska sled dogs during exercise. Circulation Research 24 (1969) 33-42
18. Madjdpour C., Spahn D.R., and Weiskopf R.B. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Critical Care Medicine 34 (2006) S102-S108
19. Carson J.L., Duff A., Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996) 1055-1060
20. van der Linden P., De Hert S., Mathieu N., et al. Tolerance to acute isovolemic hemodilution. Effect of anesthetic depth. Anesthesiology 99 (2003) 97-104
21. Vernon D.D., and Witte M.K. Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Critical Care Medicine 28 (2000) 1569-1571
22. Perez-de-Sa V., Roscher R., Cunha-Goncalves D., et al. Mild hypothermia has minimal effects on the tolerance to severe progressive normovolemic anemia in Swine. Anesthesiology 97 (2002) 1189-1197
23. Habler O.P., and Messmer K.F. Hyperoxaemia in extreme haemodilution. British Journal of Anaesthesia 81 supplement 1 (1998) 79-82
24. Pape A., Meier J., Kertscho H., et al. Hyperoxic ventilation increases the tolerance of acute normovolemic anemia in anesthetized pigs. Critical Care Medicine 34 (2006) 1475-1482
25. Habler O.P., Kleen M.S., Hutter J.W., et al. Hemodilution and intravenous perflubron emulsion as an alternative to blood transfusion: effects on tissue oxygenation during profound hemodilution in anesthetized dogs. Transfusion 38 (1998) 145-155
26. Habler O.P., Kleen M.S., Hutter J.W., et al. Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs. Transfusion 38 (1998) 135-144
27. Habler O. Cardiac high-risk patients: From 'permissive' to 'deliberate' anemia. Critical Care Medicine 33 (2005) 2434-2435
28. Vamvakas E.C., and Pineda A.A. Autologous transfusion and other approaches to reduce allogeneic blood exposure. Baillière's Best Practice & Research. Clinical Haematology 13 (2000) 533-547
29. Karger R., and Kretschmer V. Modern concepts of autologous haemotherapy. Transfusion and Apheresis Science 32 (2005) 185-196
30. Rogers B.A., and Johnstone D.J. Audit on the efficient use of cross-matched blood in elective total hip and total knee replacement. Annals of the Royal College of Surgeons of England 88 (2006) 199-201
31. Hutton B., Fergusson D., Tinmouth A., et al. Transfusion rates vary significantly amongst Canadian medical centres. Canadian Journal of Anaesthesia 52 (2005) 581-590
32. Keating E.M., and Meding J.B. Perioperative blood management practices in elective orthopaedic surgery. The Journal of the American Academy of Orthopaedic Surgeons 10 (2002) 393-400
33. Habler O.P., and Messmer K.F. Verfahren zur Reduktion von Fremdblut in der operativen Medizin. Anaesthesist 46 (1997) 915-926
34. Shander A. Surgery without blood. Critical Care Medicine 31 (2003) S708-S714
35. Carless P., Moxey A., O'Connell D., and Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfusion Medicine (Oxford, England) 14 (2004) 123-144
36. Messmer K., and Sunder-Plassmann L. Hemodilution. Progress in Surgery 13 (1974) 208-245
37. Murray D. Acute normovolemic hemodilution. European Spine Journal 13 (2004) S72-S75
38. Weiskopf R.B. Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 94 (2001) 439-446
39. Matot I., Scheinin O., Jurim O., and Eid A. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 97 (2002) 794-800
40. Wong J.C., Torella F., Haynes S.L., et al. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Annals of Surgery 235 (2002) 145-151
41. Bennett J., Haynes S., Torella F., et al. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion 46 (2006) 1097-1103
42. Terada N., Arai Y., Matsuta Y., et al. Acute normovolemic hemodilution for radical prostatectomy: can it replace preoperative autologous blood transfusion?. International Journal of Urology 8 (2001) 149-152
43. Habler O.P., Schwenzer K., Zimmer K., et al. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. International Journal of Oral and Maxillofacial Surgery 33 (2004) 467-475
44. Bryson G.L., Laupacis A., and Wells G.A. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesthesia and Analgesia 86 (1998) 9-15
45. Segal J.B., Blasco-Colmenares E., Norris E.J., and Guallar E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 44 (2004) 632-644
46. Monk T.G., Goodnough L.T., Brecher M.E., et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 91 (1999) 24-33
47. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105 (2006) 198-208
48. Cuenca J., Garcia-Erce J.A., Martinez F., et al. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 46 (2006) 1112-1119
49. Andrews C.M., Lane D.W., and Bradley J.G. Iron pre-load for major joint replacement. Transfusion Medicine (Oxford, England) 7 (1997) 281-286
50. Goodnough L.T., Skikne B., and Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 96 (2000) 823-833
51. Chun T.Y., Martin S., and Lepor H. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology 50 (1997) 727-732
52. Dai B., Wang L., Djaiani G., and Mazer C.D. Continuous and discontinuous cell-washing autotransfusion systems. Journal of Cardiothoracic and Vascular Anesthesia 18 (2004) 210-217
53. Waters J.H. Indications and contraindications of cell salvage. Transfusion 44 (2004) 40S-44S
54. Bowley D.M., Barker P., and Boffard K.D. Intraoperative Blood Salvage in Penetrating Abdominal Trauma: a Randomised, Controlled Trial. World Journal of Surgery 30 (2006) 1074-1080
55. Hansen E., Bechmann V., and Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective?. Transfusion and Apheresis Science 27 (2002) 153-157
56. Beck-Schimmer B., Romero B., Booy C., et al. Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. European Journal of Anaesthesiology 21 (2004) 46-52
57. Catling S., and Joels L. Cell salvage in obstetrics: the time has come. BJOG: an International Journal of Obstetrics and Gynaecology 112 (2005) 131-132
58. Waters J.H., Biscotti C., Potter P.S., and Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 92 (2000) 1531-1536
59. Huet C., Salmi L.R., Fergusson D., et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesthesia and Analgesia 89 (1999) 861-869
60. Gohel M.S., Bulbulia R.A., Slim F.J., et al. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Annals of the Royal College of Surgeons of England 87 (2005) 3-14
61. Habler O.P., Pape A., Meier J., and Zwissler B. Künstliche Sauerstoffträger als Alternative zur Bluttransfusion. Anaesthesist 54 (2005) 741-754
62. Spahn D.R., and Kocian R. Artificial O2 carriers: status in 2005. Current Pharmaceutical Design 11 (2005) 4099-4114
63. Riess J.G. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 33 (2005) 47-63
64. Spahn D.R., Willimann P.F., and Faithfull N.S. Die Wirksamkeit der Augmentierten Akuten Normovolämen Hämodilution (A-ANH™). Anaesthesist 50 supplement 1 (2001) S49-S54
65. Spahn D.R., and Kocian R. The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation. Canadian Journal of Anaesthesia 50 (2003) S41-S47
66. Habler O.P., Kleen M.S., Hutter J.W., et al. IV perflubron emulsion versus autologous transfusion in severe normovolemic anemia: effects on left ventricular perfusion and function. Research in Experimental Medicine 197 (1998) 301-318
67. Frumento R.J., Mongero L., Naka Y., and Benett-Guerrero E. Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion. Anesthesia and Analgesia 94 (2002) 809-814
68. Spahn D.R., van B.R., Theilmeier G., et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology 91 (1999) 1195-1208
69. Spahn D.R., Waschke K.F., Standl T., et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology 97 (2002) 1338-1349
70. 2 carriers. ISBT Science Series 1 1 (2006) 152-160
71. Moore E.E. Blood substitutes: the future is now. Journal of the American College of Surgeons 196 (2003) 1-17
72. Alayash A.I. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?. Nature Biotechnology 17 (1999) 545-549
73. Habler O.P., Kleen M.S., Pape A., et al. Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Critical Care Medicine 28 (2000) 1889-1898
74. Nolte D., Steinhauser P., Pickelmann S., et al. Effects of diaspirin-cross-linked hemoglobin (DCLHb) on local tissue oxygen tension in striated skin muscle: an efficacy study in the hamster. The Journal of Laboratory and Clinical Medicine 130 (1997) 328-338
75. Schultz S.C., Hamilton I.N.J., and Malcolm D.S. Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. The Journal of Trauma 35 (1993) 619-625
76. Sprung J., Mackenzie C.F., Barnas G.M., et al. Oxygen transport and cardiovascular effects of resuscitation from severe hemorrhagic shock using hemoglobin solutions. Critical Care Medicine 23 (1995) 1540-1553
77. Johnson J.L., Moore E.E., Gonzalez R.J., et al. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. The Journal of Trauma 54 (2003) 133-139
78. Pickelmann S., Nolte D., Leiderer R., et al. Attenuation of postischemic reperfusion injury in striated skin muscle by diaspirin-cross-linked Hb. The American Journal of Physiology 275 (1998) H361-H368
79. Botzlar A., Nolte D., and Messmer K. Effects of ultra-purified polymerized bovine hemoglobin on the microcirculation of striated skin muscle in the hamster. European Journal of Medical Research 1 (1996) 471-478
80. Sloan E.P., Koenigsberg M., Gens D., et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA: The Journal of the American Medical Association 282 (1999) 1857-1864
81. Sloan E.P., Koenigsberg M., Brunett P.H., et al. Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock. The Journal of Trauma 52 (2002) 887-895
82. Gould S.A., Moore E.E., Hoyt D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. Journal of the American College of Surgeons 195 (2002) 445-452
83. Cheng D.C., Mazer C.D., Martineau R., et al. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. The Journal of Thoracic and Cardiovascular Surgery 127 (2004) 79-86
84. Greenburg A.G., and Kim H.W. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. Journal of the American College of Surgeons 198 (2004) 373-383
85. Garrioch M.A., McClure J.H., and Wildsmith J.A. Haemodynamic effects of diaspirin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. British Journal of Anaesthesia 83 (1999) 702-707
86. Kasper S.M., Walter M., Grune F., et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesthesia and Analgesia 83 (1996) 921-927
87. Lamy M.L., Daily E.K., Brichant J.F., et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology 92 (2000) 646-656
88. Schubert A., Przybelski R.J., Eidt J.F., et al. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesthesia and Analgesia 97 (2003) 323-332
89. Hayes J.K., Stanley T.H., Lind G.H., et al. A double-blind study to evaluate the safety of recombinant human hemoglobin in surgical patients during general anesthesia. Journal of Cardiothoracic and Vascular Anesthesia 15 (2001) 593-602
90. Sprung J., Kindscher J.D., Wahr J.A., et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesthesia and Analgesia 94 (2002) 799-808
91. Kazmierczak S.C., Catrou P.G., Best A.E., et al. Multiple regression analysis of interference effects from a hemoglobin-based oxygen carrier solution. Clinical Chemistry and Laboratory Medicine 37 (1999) 453-464
92. Mullon J., Giacoppe G., Clagett C., et al. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. The New England Journal of Medicine 342 (2000) 1638-1643
93. Lanzkron S., Moliterno A.R., Norris E.J., et al. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion 42 (2002) 1422-1427
94. Pape A., Kleen M.S., Kemming G.I., et al. Fluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusion. Acta Anaesthesiologica Scandinavica 48 (2004) 1328-1337
95. Pape A., Kemming G.I., Meisner F.G., et al. Diaspirin cross-linked hemoglobin fails to improve left ventricular diastolic function after fluid resuscitation from hemorrhagic shock. European Surgical Research 33 (2001) 318-326
96. Vandegriff K.D., Malavalli A., Wooldridge J., et al. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43 (2003) 509-516
97. Wettstein R., Tsai A.G., Erni D., et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Critical Care Medicine 31 (2003) 1824-1830
98. Winslow R.M. Current status of oxygen carriers ('blood substitutes'): 2006. Vox Sanguinis 91 (2006) 102-110
99. van Woerkens E.C., Trouwborst A., and van Lanschot J.J. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?. Anesthesia and Analgesia 75 (1992) 818-821
100. Kemming G.I., Meisner F.G., Kleen M.S., et al. Hyperoxic ventilation at the critical haematocrit. Resuscitation 56 (2003) 289-297
101. Meisner F.G., Kemming G.I., Habler O.P., et al. Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit. Critical Care Medicine 29 (2001) 829-838